A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

BACKGROUND: In vitro drug screening studies have indicated that camostat mesilate (FOY-305) may prevent SARS-CoV-2 infection into human airway epithelial cells. This study was conducted to investigate whether camostat mesilate is an effective treatment for SARS-CoV-2 infection (COVID-19). METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Taku, Shinoda, Masahiro, Nishizaki, Yasuhiro, Shiraki, Katsuya, Hirai, Yuji, Kichikawa, Yoshiko, Tsushima, Kenji, Sinkai, Masaharu, Komura, Naoyuki, Yoshida, Kazuo, Kido, Yasutoshi, Kakeya, Hiroshi, Uemura, Naoto, Kadota, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512971/
https://www.ncbi.nlm.nih.gov/pubmed/36163020
http://dx.doi.org/10.1186/s12916-022-02518-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512971/
https://www.ncbi.nlm.nih.gov/pubmed/36163020
http://dx.doi.org/10.1186/s12916-022-02518-7

Ejemplares similares